Bioventix (LON:BVXP) Insider Bruce Hiscock Acquires 534 Shares of Stock

Bioventix PLC (LON:BVXP) insider Bruce Hiscock purchased 534 shares of the business’s stock in a transaction dated Wednesday, June 24th. The stock was bought at an average price of GBX 1,799 per share, for a total transaction of £9,606.66.

Bruce Hiscock also recently made the following trade(s):

• On Monday, April 27th, Bruce Hiscock purchased 66 shares of Bioventix stock. The stock was purchased at an average cost of GBX 1,679 per share, for a total transaction of £1,108.14.

Bioventix Trading Down 5.0%

Shares of BVXP stock traded down GBX 90 during trading hours on Wednesday, reaching GBX 1,710. 38,243 shares of the company’s stock were exchanged, compared to its average volume of 10,349. Bioventix PLC has a fifty-two week low of GBX 1,300 and a fifty-two week high of GBX 3,020. The stock’s 50 day moving average is GBX 1,697.30 and its 200-day moving average is GBX 1,695.99. The company has a market cap of £89.35 million, a price-to-earnings ratio of 12.17 and a beta of 0.55.

Bioventix (LON:BVXP) last issued its quarterly earnings results on Monday, March 30th. The biotechnology company reported GBX 69.38 earnings per share for the quarter. The business had revenue of GBX 615.88 billion for the quarter. Bioventix had a return on equity of 65.83% and a net margin of 59.30%. Equities analysts anticipate that Bioventix PLC will post 166.3066955 EPS for the current year.

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.